{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T11:02:46Z","timestamp":1764154966401,"version":"3.46.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":217,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse reaction characterised by fever, lymphadenopathy, morbilliform rash, haematologic abnormalities, and multiorgan involvement. Herein, we describe a 32-year-old female presenting with a 9-day history of facial oedema, cervical and inguinal lymphadenopathy, and a pruritic rash comprised of vesicles and pustules on her face, trunk, and extremities. Her only medications were valproate, which she had been taking for several years, and levetiracetam, which was initiated 41 days prior to rash onset. On the 16th day of her rash, she was diagnosed with DRESS induced by levetiracetam (Registry of Severe Cutaneous Adverse Reactions: 5). At this point, her absolute eosinophil count was 0.9 \u00d7 109 cells\/L and aspartate and alanine transaminase levels were 357 and 339 U\/L, respectively. Pustules with a morbilliform rash may occur in up to 30% of DRESS cases. In rarer instances, as in our patient, DRESS can present with isolated pustules and vesicles. Similarly, although rare, DRESS can be induced by levetiracetam.<\/jats:p>","DOI":"10.1002\/ski2.384","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T06:44:34Z","timestamp":1712817874000},"source":"Crossref","is-referenced-by-count":0,"title":["Vesiculopustular Drug Reaction with Eosinophilia and Systemic Symptoms Induced by Levetiracetam"],"prefix":"10.1093","volume":"4","author":[{"given":"Thomas","family":"Norman","sequence":"first","affiliation":[{"name":"Keck School of Medicine, University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Guenther","sequence":"additional","affiliation":[{"name":"Keck School of Medicine, University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keck School of Medicine, University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney","family":"DeClerck","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keck School of Medicine, University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Worswick","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keck School of Medicine, University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"issue":"23","key":"2025112605421708800_ski2384-bib-0001","first-page":"02402","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathologic features, and prognosis","volume":"S0190-9622","author":"Wei","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"23","key":"2025112605421708800_ski2384-bib-0002","doi-asserted-by":"publisher","first-page":"02403","DOI":"10.1016\/j.jaad.2023.02.073","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part II. Diagnosis and management","volume":"S0190-9622","author":"Wei","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2025112605421708800_ski2384-bib-0003","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"issue":"9","key":"2025112605421708800_ski2384-bib-0004","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1111\/jdv.18100","article-title":"Skin manifestations and clinical features of drug reaction with eosinophilia and systemic symptoms: a retrospective multicentre study of 125 patients","volume":"36","author":"Lee","year":"2022","journal-title":"J Eur Acad Dermatol Venerol"},{"issue":"2","key":"2025112605421708800_ski2384-bib-0005","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/1346-8138.12028","article-title":"Pustular-type drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement","volume":"40","author":"Matsuda","year":"2013","journal-title":"J Dermatol"},{"key":"2025112605421708800_ski2384-bib-0006","first-page":"207","article-title":"Pustular DRESS syndrome secondary to hydroxychloroquine with EBV reactivation","volume":"18","author":"Girijala","year":"2019","journal-title":"J Drugs Dermatol JDD"},{"issue":"2","key":"2025112605421708800_ski2384-bib-0007","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/bjd.12081","article-title":"Drug reactions with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases","volume":"168","author":"Walsh","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"2025112605421708800_ski2384-bib-0008","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"issue":"1","key":"2025112605421708800_ski2384-bib-0009","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-72","article-title":"Toxic epidermal neurolysis, DRESS, AGEP: do overlap cases exist?","volume":"7","author":"Bouvresse","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2025112605421708800_ski2384-bib-0010","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/bjd.12783","article-title":"Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"170","author":"Chi","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"2025112605421708800_ski2384-bib-0011","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/bjd.13683","article-title":"Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study","volume":"173","author":"Ortonne","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"2025112605421708800_ski2384-bib-0012","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042147","article-title":"Current perspectives regarding the immunopathogenesis of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS)","volume":"22","author":"Miyagawa","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2025112605421708800_ski2384-bib-0013","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"2025112605421708800_ski2384-bib-0014","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.seizure.2020.01.002","article-title":"Levetiracetam and cutaneous adverse reactions: a systematic review of descriptive studies","volume":"75","author":"Rashid","year":"2020","journal-title":"Seizure"},{"issue":"5","key":"2025112605421708800_ski2384-bib-0015","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4168\/aair.2019.11.5.709","article-title":"Severe cutaneous adverse reactions to antiepileptic drugs: a nationwide registry-based study in Korea","volume":"11","author":"Park","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"issue":"5","key":"2025112605421708800_ski2384-bib-0016","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/bf03256336","article-title":"In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review","volume":"13","author":"Elzagallaai","year":"2009","journal-title":"Mol Diagn Ther"},{"issue":"6","key":"2025112605421708800_ski2384-bib-0017","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/cod.14090","article-title":"Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): a literature review","volume":"86","author":"de Groot","year":"2022","journal-title":"Contact Dermatitis"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/4\/ski2.384\/60660652\/skinhd_4_4_e384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/4\/ski2.384\/60660652\/skinhd_4_4_e384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:42:24Z","timestamp":1764153744000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.384\/7896817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,11]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.384","relation":{},"ISSN":["2690-442X"],"issn-type":[{"type":"electronic","value":"2690-442X"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,4,11]]},"article-number":"ski2.384"}}